Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2021-08-31 Director's Dealing
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Exercise of employee share options
Director's Dealing Classification · 99% confidence The document is titled "NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19". It details a transaction involving a 'person discharging managerial responsibilities' (Geoffrey Coy) and reports the purchase of shares. This structure and content are characteristic of insider trading disclosures, specifically reporting personal share transactions by directors and executives. This directly matches the definition for Director's Dealing (DIRS).
2021-08-31 English
Photocure ASA: Exercise of employee share options
Director's Dealing Classification · 98% confidence The document explicitly discusses the exercise of employee share options by a primary insider (Geoffrey Coy, VP & General Manager US Operations) and the subsequent purchase of shares using the net proceeds. It references 'Primary insider notification pursuant to the market abuse regulation article 19'. This type of transaction—insider trading/dealing following option exercise—is specifically covered by the Director's Dealing (DIRS) category. Although it involves share transactions, the core subject is the insider's personal dealing activity, not a general share repurchase program (POS) or a general capital change (SHA). The document is a direct announcement of this insider activity.
2021-08-31 English
Photocure ASA: Exercise of employee share options
Director's Dealing Classification · 98% confidence The document explicitly discusses the 'Exercise of employee share options' by a primary insider (Geoffrey Coy, VP & General Manager US Operations). It details the transaction price and the subsequent purchase of shares using net proceeds. This type of transaction, involving personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions a 'Primary insider notification pursuant to the market abuse regulation article 19 is attached,' the core content is the insider transaction itself, making DIRS the most specific fit over a general regulatory filing (RNS) or a transaction in own shares (POS), as POS usually refers to the company's own buyback program, not insider option exercises.
2021-08-31 English
Photocure ASA: Exercise of employee share options and share capital increase
Director's Dealing Classification · 99% confidence The document is explicitly titled "NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19". It details a transaction (exercise of share options) by a 'Person discharging managerial responsibilities' (Geoffrey Coy) concerning shares of PHOTOCURE ASA. This type of filing, reporting insider transactions by management, directly corresponds to the definition of Director's Dealing (DIRS). It is not an Annual Report (10-K), Earnings Release (ER), or a general regulatory filing (RNS), as it fits a specific insider transaction category.
2021-08-30 English
Photocure ASA: Exercise of employee share options and share capital increase
Share Issue/Capital Change Classification · 99% confidence The document explicitly details the exercise of employee share options, the subsequent increase in share capital by issuing new shares, and includes a notification regarding a primary insider's transaction (Geoffrey Coy). This directly relates to changes in the company's share structure and insider dealings. The options exercise leads to a share capital increase, which falls under 'Share Issue/Capital Change' (SHA). Furthermore, the notification of the primary insider's transaction (Geoffrey Coy) aligns with 'Director's Dealing' (DIRS). Since the core event is the issuance of new shares following option exercise, SHA is the most precise fit for the primary action described. The mention of the insider transaction is secondary to the capital change itself, although DIRS is also highly relevant. Given the explicit mention of 'share capital increase' and 'issuing 25,500 new shares', SHA is the primary classification.
2021-08-30 English
Photocure ASA: Exercise of employee share options and share capital increase
Share Issue/Capital Change Classification · 99% confidence The document explicitly details the exercise of employee share options, the resulting increase in share capital, and includes a notification regarding a primary insider's transaction (Geoffrey Coy). This directly relates to changes in the company's share structure and insider dealings. The most fitting categories are 'Share Issue/Capital Change' (SHA) or 'Director's Dealing' (DIRS). Since the core event is the capital increase resulting from option exercise, and it mentions the insider transaction separately (which will be announced later), 'Share Issue/Capital Change' (SHA) is the primary classification for the capital increase aspect. However, the document also strongly features the insider transaction notification required by MAR Article 19. Given the options, 'SHA' covers the capital increase, and 'DIRS' covers the insider dealing. Since the document announces both the capital increase (25,500 new shares issued) and the insider transaction (22,500 options exercised by an insider), and the capital change is a direct consequence, SHA is a strong fit. Alternatively, 'DIRS' focuses on the insider aspect. Looking at the definitions, 'SHA' (Share Issue/Capital Change) covers the capital structure change, and 'DIRS' (Director's Dealing) covers the insider transaction. Since the document is a formal announcement detailing the mechanics of the share issuance due to option exercise, SHA is appropriate. If the focus was purely on the insider's trade details, DIRS would be better. Given the dual nature, and the explicit mention of 'share capital increase', SHA is selected as the primary corporate action being reported, while acknowledging the insider element.
2021-08-30 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.